OHSU
Return to Listing

1 result(s) for US-ATG-F

PI Name Protocol # Title
Richard Maziarz IRB00008664 A randomized, prospective, double blind, placebo-controlled, phase 3 study of US- ATG-F prophylaxis as a supplement to standard of care prophylaxis to prevent moderate to severe chronic GVHD in adult acute myeloid leukemia, acute lymphoid leukemia, and myelodysplastic syndrome patients after allogeneic stem cell transplantation from unrelated donors (IV-ATG-SCT-01)
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080
 

You may qualify for additional trials within our Phase 1 Program